SCHEMBL193055

SCHEMBL193055

Cc1[c]nc(C)cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL790743 0.74
SCHEMBL2408169 0.66 NOS3 (0.35)
SCHEMBL82304 0.64
SCHEMBL31520440 0.61 UHRF1 (0.41)
Ammonia Solution, Strong SCHEMBL27508580 0.61
SCHEMBL15278266 0.57
SCHEMBL194643 0.56
SCHEMBL558287 0.56
SCHEMBL413183 0.56
SCHEMBL7976283 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 264 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230129359-A1 MUSCARINIC RECEPTOR 4 ANTAGONISTS AND METHODS OF USE NEUROCRINE BIOSCIENCES, INC. 2023-04-27 US claimed
EP-4100410-A1 MUSCARINIC RECEPTOR 4 ANTAGONISTS AND METHODS OF USE Neurocrine Biosciences, Inc. (US) 2022-12-14 EP claimed
CN-115362156-A Muscarinic receptor 4 antagonists and methods of use 纽罗克里生物科学有限公司 2022-11-18 CN claimed
WO-2021158698-A1 MUSCARINIC RECEPTOR 4 ANTAGONISTS AND METHODS OF USE NEUROCRINE BIOSCIENCES, INC. (US) 2021-08-12 WO claimed
US-9062044-B2 Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2015-06-23 US claimed
US-8980888-B2 Pyrazole derivative MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2015-03-17 US claimed
US-20140378447-A1 NOVEL PYRAZOLE DERIVATIVE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2014-12-25 US claimed
US-8680275-B2 Fused heterocyclic compounds as orexin receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2014-03-25 US claimed
EP-2491034-B1 FUSED HETEROCYCLIC COMPOUNDS AS OREXIN RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2013-12-18 EP claimed
EP-2491031-B1 FUSED HETEROCYCLIC COMPOUNDS AS OREXIN RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2013-08-07 EP claimed
CN-1277604-A Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors NEUROSEARCH AS (DK) 2000-12-20 CN claimed
EP-1027336-A1 HETEROARYL DIAZACYCLOALKANES AS CHOLINERGIC LIGANDS AT NICOTINIC ACETYLCHOLINE RECEPTORS NEUROSEARCH A/S (DK) 2000-08-16 EP claimed
WO-1999021834-A1 HETEROARYL DIAZACYCLOALKANES AS CHOLINERGIC LIGANDS AT NICOTINIC ACETYLCHOLINE RECEPTORS NEUROSEARCH A/S (DK) 1999-05-06 WO claimed
WO-1995022543-A1 DINITROGENATED HETEROCYCLIC DERIVATIVES HAVING AII-ANTAGONISTIC ACTIVITY LABORATORI GUIDOTTI S.P.A. (IT) 1995-08-24 WO claimed
US-5430031-A Serotoninergic ergoline derivatives FARMITALIA CARLO ERBA S.R.L. (IT) 1995-07-04 US claimed
EP-0628042-A1 SEROTONINERGIC ERGOLINE DERIVATIVES PHARMACIA &amp; UPJOHN S.p.A. (IT) 1994-12-14 EP claimed
WO-1994014806-A1 SEROTONINERGIC ERGOLINE DERIVATIVES FARMITALIA CARLO ERBA S.R.L. (IT) 1994-07-07 WO claimed
US-5180727-A Insecticides, miticides, nematocides BASF AKTIENGESELLSCHAFT (DE) 1993-01-19 US claimed
US-4083373-A FLAVOR, AROMA INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1978-04-11 US claimed
US-3988510-A 3-Furyl sulfides and foodstuff flavor compositions comprising same INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1976-10-26 US claimed